Rchr
J-GLOBAL ID:200901015947643105   Update date: Jan. 18, 2013

NAKAMURA Shinobu

ナカムラ シノブ | NAKAMURA Shinobu
Affiliation and department:
Research field  (4): Medical systems ,  Human pathology ,  General internal medicine (including psychosomatic medicine) ,  Hematology
Research keywords  (2): Clinical Cytology ,  Cancer Chemotherapy
Research theme for competitive and other funds  (3):
  • Cytopathologic Study on Adenocarcinoma and Its Application to Clinical Cytology
  • Induction of Apoptosis in Cancer Chemotherapy
  • Development of New Strategies for Treatment of Malignant Lymphoma
MISC (61):
Books (4):
  • Analysis of the proliferative characteristics of acute leukemic cells.
    Proceeding of the 4th Meeting of the German-Japanese Cooperative Congress of Clinical Cytology 1991
  • Morphological and biochemical studies on the discrimination between apoptosis and necrosis
    Proceedings of the 6th Meeting of the German-Japanese Cooperative Congeress of Clinical Cytology 1994
  • Clinical usefulness of Ag-NORs staining snd its scoring system in multiple myeloma
    The University of Nagoya Press Proceedings of the 6th Meeting of the German-Japanese Cooperative Congress of Clinical Cytology 1994
  • Differeces of degeneration process of human benign and cancer cells between cytoplasm and nucleus (共著)
    Proceedings of the 8th Meeting of the Japanese-German Cooperative Study Group of Clinical Cytology (Yamagiku Printing Co. Ltd.) 1998
Education (1):
  • - 1968 Kanazawa University Faculty of Medicine
Professional career (1):
  • Doctor of Medical Science (Kanazawa University)
Work history (5):
  • 1969 - 1976 Kanazawa University, Research Assistant
  • 1976 - 1983 Kanazawa University, Lecturer
  • 1983 - 2000 Kanazawa University, Associate Professor
  • 2000 - 2003 Nara Medical University, Professor
  • Nara Medical University Medical Faculty, Medical Department Professional Education, General Medicine 教授
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page